Thomas, Giju https://orcid.org/0000-0002-5910-8804
Kiernan, Colleen M.
Willmon, Parker A.
Haugen, Ezekiel
Luckenbaugh, Amy N.
Barocas, Daniel A.
Baregamian, Naira
Mahadevan‐Jansen, Anita
Solόrzano, Carmen C.
Funding for this research was provided by:
National Cancer Institute (R01CA212147)
National Cancer Institute (R01CA212147)
Article History
Accepted: 3 September 2022
First Online: 2 October 2022
Declarations
:
: A. Mahadevan-Jansen and Vanderbilt University have a licensing agreement with AiBiomed (Santa Barbara, CA) for PTeye® that has now been acquired by Medtronic, Inc. A. Mahadevan-Jansen was an equity holder at AiBiomed. Other authors have no conflicts of interest to declare.
: This study was conducted following approval by the Institutional Review Board at Vanderbilt University Medical Center. The authors are accountable for describing the study with sufficient clarity to ensure reproducibility, accuracy, and integrity of the presented data.
: Informed consent was obtained from all individual participants included in the study.